Rockwell Medical, Inc. (RMTI)
Largest Insider Buys in Sector
RMTI Stock Price History Chart
RMTI Stock Performance
About Rockwell Medical, Inc.
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as …
Insider Activity of Rockwell Medical, Inc.
Over the last 12 months, insiders at Rockwell Medical, Inc. have bought $0 and sold $11,660 worth of Rockwell Medical, Inc. stock.
On average, over the past 5 years, insiders at Rockwell Medical, Inc. have bought $51,723 and sold $446,269 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 24,681 shares for transaction amount of $47,563 was made by Richmond David S. (10 percent owner) on 2020‑06‑30.
List of Insider Buy and Sell Transactions, Rockwell Medical, Inc.
| 2024-10-01 | Sale | President and CEO | 2,163 0.0068% | $3.69 | $7,971 | -3.26% | ||
| 2024-10-01 | Sale | SVP, Chief Commercial Officer | 1,001 0.0032% | $3.69 | $3,689 | -3.26% | ||
| 2020-12-21 | Sale | 10 percent owner | 42,450 0.0609% | $1.03 | $43,724 | -13.00% | ||
| 2020-12-16 | Sale | 10 percent owner | 521,876 0.7092% | $1.01 | $529,649 | -15.87% | ||
| 2020-12-15 | Sale | 10 percent owner | 278,124 0.3947% | $1.11 | $307,505 | -19.27% | ||
| 2020-06-30 | 10 percent owner | 24,681 0.034% | $1.93 | $47,563 | -43.33% | |||
| 2020-05-14 | See Remarks | 2,000 0.003% | $2.08 | $4,160 | -38.50% | |||
| 2019-08-02 | 10 percent owner | 97 0.0002% | $2.42 | $235 | -5.31% | |||
| 2019-07-31 | 10 percent owner | 1,807 0.0028% | $2.66 | $4,806 | -12.78% | |||
| 2019-07-29 | Sale | director | 179 0.0003% | $3.12 | $558 | -25.64% | ||
| 2019-07-25 | 10 percent owner | 319 0.0005% | $3.06 | $976 | -23.61% | |||
| 2019-07-24 | 10 percent owner | 2,579 0.004% | $3.13 | $8,072 | -25.80% | |||
| 2019-07-22 | 10 percent owner | 92,707 0.1463% | $2.99 | $277,194 | -20.88% | |||
| 2019-07-19 | 10 percent owner | 68,750 0.1031% | $2.89 | $198,688 | -21.85% | |||
| 2019-07-08 | 10 percent owner | 9,780 0.0154% | $3.05 | $29,788 | -21.12% | |||
| 2019-07-01 | Chief Executive Officer | 10,000 0.0156% | $2.97 | $29,700 | -20.07% | |||
| 2019-06-28 | Chief Financial Officer | 10,000 0.0175% | $3.06 | $30,600 | -20.27% | |||
| 2019-05-09 | 10 percent owner | 4,643 0.0081% | $5.65 | $26,211 | -55.48% | |||
| 2019-03-27 | 10 percent owner | 5,869 0.0103% | $5.59 | $32,788 | -52.06% | |||
| 2018-10-15 | 10 percent owner | 5.54M 50.7095% | $22.00 | $121.91M | -22.84% |
Insider Historical Profitability
| CHIOINI ROBERT L | Chairman, President and CEO | 1793933 5.7812% | $4.13 | 2 | 9 | <0.0001% |
| Richmond David S. | 10 percent owner | 1433309 4.6191% | $4.13 | 16 | 4 | <0.0001% |
| HAGELSTEIN DAVID A | 10 percent owner | 1360700 4.3851% | $4.13 | 34 | 4 | +6.89% |
| Paul Stuart M | Chief Executive Officer | 363798 1.1724% | $4.13 | 1 | 0 | <0.0001% |
| Gupta Ajay | Chief Scientific Officer | 326667 1.0527% | $4.13 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Armistice Capital Llc | $4.37M | 8.67 | 2.63M | +41.99% | +$1.29M | 0.01 | |
| The Vanguard Group | $1.86M | 3.69 | 1.12M | +4.03% | +$71,881.33 | <0.0001 | |
| Perkins Capital Management Inc | $579,000.00 | 1.15 | 348,684 | -0.36% | -$2,075.66 | 0.5 | |
| Richmond Brothers, Inc. | $534,950.00 | 1.06 | 322,251 | -21.87% | -$149,705.85 | 1 | |
| Geode Capital Management | $479,464.00 | 0.95 | 288,760 | +1.7% | +$8,031.47 | <0.0001 |